BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36472792)

  • 21. Haploidentical hematopoietic stem cell transplantation may improve long-term survival for children with high-risk T-cell acute lymphoblastic leukemia in first complete remission.
    Zhang Y; Bai L; Cheng Y; Lu A; Wang Y; Wu J; Zhang X; Zuo Y; Xu L; Jia Y; Huang X; Zhang L
    Chin Med J (Engl); 2022 Apr; 135(8):940-949. PubMed ID: 35730372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in epigenetic regulators are involved in acute lymphoblastic leukemia relapse following allogeneic hematopoietic stem cell transplantation.
    Xiao H; Wang LM; Luo Y; Lai X; Li C; Shi J; Tan Y; Fu S; Wang Y; Zhu N; He J; Zheng W; Yu X; Cai Z; Huang H
    Oncotarget; 2016 Jan; 7(3):2696-708. PubMed ID: 26527318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of second transplantation with T-cell-replete haploidentical graft using low-dose anti-thymocyte globulin on long-term overall survival in pediatric patients with relapse of leukemia after first allogeneic transplantation.
    Kobayashi S; Sano H; Mochizuki K; Ohara Y; Takahashi N; Kudo S; Ikeda K; Ohto H; Kikuta A
    Int J Hematol; 2022 Mar; 115(3):414-423. PubMed ID: 34822127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Umbilical cord blood transplantation can overcome the poor prognosis of KMT2A-MLLT3 acute myeloid leukemia and can lead to good GVHD-free/relapse-free survival.
    Tong J; Zhang L; Liu H; Xu X; Zheng C; Yao W; Zhu X; Tang B; Wan X; Song K; Zhang X; Sun G; Sun Z
    Ann Hematol; 2021 May; 100(5):1303-1309. PubMed ID: 33469688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors of children and adolescents with T-cell acute lymphoblastic leukemia after allogeneic transplantation.
    Ishida H; Kato M; Kawahara Y; Ishimaru S; Najima Y; Kako S; Sato M; Hiwatari M; Noguchi M; Kato K; Koh K; Okada K; Iwasaki F; Kobayashi R; Igarashi S; Saito S; Takahashi Y; Sato A; Tanaka J; Hashii Y; Atsuta Y; Sakaguchi H; Imamura T
    Hematol Oncol; 2022 Aug; 40(3):457-468. PubMed ID: 35212019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute megakaryoblastic leukemia in children: treatment with bone marrow transplantation.
    de Oliveira JS; Sale GE; Bryant EM; Sanders J; Buckner CD
    Bone Marrow Transplant; 1992 Nov; 10(5):399-403. PubMed ID: 1463999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minimal residual disease monitoring and preemptive immunotherapies for frequent 11q23 rearranged acute leukemia after allogeneic hematopoietic stem cell transplantation.
    Liu J; Zhang XH; Xu LP; Wang Y; Yan CH; Chen H; Chen YH; Han W; Wang FR; Wang JZ; Cheng YF; Qin YZ; Liu KY; Huang XJ; Zhao XS; Mo XD
    Ann Hematol; 2021 May; 100(5):1267-1281. PubMed ID: 33712867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A t(11;14)(p13;q11) specific for T-cell malignancies in acute megakaryoblastic leukemia.
    Shikano T; Kaneko T; Konishi T; Satake Y
    Cancer Genet Cytogenet; 1995 Aug; 83(1):42-5. PubMed ID: 7656203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistent donor derived Vδ4 T cell clones may improve survival for recurrent T cell acute lymphoblastic leukemia after HSCT and DLI.
    Xu L; Weng J; Huang X; Zeng C; Chen S; Geng S; Yang L; Wu S; Huang S; Du X; Li Y
    Oncotarget; 2016 Jul; 7(28):42943-42952. PubMed ID: 27356746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The adverse impact of ecotropic viral integration site-1 (EVI1) overexpression on the prognosis of acute myeloid leukemia with KMT2A gene rearrangement in different risk stratification subtypes.
    Liu XX; Pan XA; Gao MG; Kong J; Jiang H; Chang YJ; Zhang XH; Wang Y; Liu KY; Chen Z; Zhao XS; Huang XJ
    Int J Lab Hematol; 2023 Apr; 45(2):195-203. PubMed ID: 36358022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted therapy using larotrectinib and venetoclax for the relapsed/refractory T-cell acute lymphoblastic leukemia harboring a cryptic ETV6-NTRK3 fusion.
    Zhou K; Gong D; He C; Xiao M; Zhang M; Huang W
    Mol Carcinog; 2023 Jul; 62(7):899-906. PubMed ID: 37036164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistent Multiyear Control of Relapsed T-Cell Acute Lymphoblastic Leukemia With Successive Donor Lymphocyte Infusions: A Case Report.
    Huo JS; Symons HJ; Robey N; Borowitz MJ; Schafer ES; Chen AR
    Pediatr Blood Cancer; 2016 Jul; 63(7):1279-82. PubMed ID: 26990138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute megakaryoblastic leukemia, unlike acute erythroid leukemia, predicts an unfavorable outcome after allogeneic HSCT.
    Ishiyama K; Yamaguchi T; Eto T; Ohashi K; Uchida N; Kanamori H; Fukuda T; Miyamura K; Inoue Y; Taguchi J; Mori T; Iwato K; Morishima Y; Nagamura-Inoue T; Atsuta Y; Sakamaki H; Takami A
    Leuk Res; 2016 Aug; 47():47-53. PubMed ID: 27244257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and In Vitro Studies on Impact of High-Dose Etoposide Pharmacokinetics Prior Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Lymphoblastic Leukemia on the Risk of Post-Transplant Leukemia Relapse.
    Sobiak J; Kazimierczak U; Kowalczyk DW; Chrzanowska M; Styczyński J; Wysocki M; Szpecht D; Wachowiak J
    Arch Immunol Ther Exp (Warsz); 2015 Oct; 63(5):385-95. PubMed ID: 26040247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome.
    Hara Y; Shiba N; Ohki K; Tabuchi K; Yamato G; Park MJ; Tomizawa D; Kinoshita A; Shimada A; Arakawa H; Saito AM; Kiyokawa N; Tawa A; Horibe K; Taga T; Adachi S; Taki T; Hayashi Y
    Genes Chromosomes Cancer; 2017 May; 56(5):394-404. PubMed ID: 28063190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Analysis of Clinical Characteristics and Prognosis in Children with Acute Megakaryoblastic Leukemia without Down Syndrome].
    Lin SF; Guo SY; Liu S; Wang J; Huang K; Li Y; Fang JP; Zhou DH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):374-380. PubMed ID: 33812402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NOTCH1 pathway activating mutations and clonal evolution in pediatric T-cell acute lymphoblastic leukemia.
    Kimura S; Seki M; Yoshida K; Shiraishi Y; Akiyama M; Koh K; Imamura T; Manabe A; Hayashi Y; Kobayashi M; Oka A; Miyano S; Ogawa S; Takita J
    Cancer Sci; 2019 Feb; 110(2):784-794. PubMed ID: 30387229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Courses of Two Pediatric Patients with Acute Megakaryoblastic Leukemia Harboring the CBFA2T3-GLIS2 Fusion Gene.
    Ishibashi M; Yokosuka T; Yanagimachi MD; Iwasaki F; Tsujimoto SI; Sasaki K; Takeuchi M; Tanoshima R; Kato H; Kajiwara R; Tanaka F; Goto H; Yokota S
    Turk J Haematol; 2016 Dec; 33(4):331-334. PubMed ID: 27094503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mixed-phenotype acute leukemia, T/megakaryoblastic.
    Klairmont MM; Choi JK
    Blood; 2018 Nov; 132(22):2418. PubMed ID: 30498070
    [No Abstract]   [Full Text] [Related]  

  • 40. Prognosis of haploidentical hematopoietic stem cell transplantation in non-infant children with t(v;11q23)/MLL-rearranged B-cell acute lymphoblastic leukemia.
    Bai L; Cheng YF; Lu AD; Suo P; Wang Y; Zuo YX; Yan CH; Wu J; Jia YP; Sun YQ; Chen YH; Chen H; Liu KY; Han W; Xu LP; Wang JB; Tang XF; Chen HR; Zhang LP; Huang XJ
    Leuk Res; 2020 Apr; 91():106333. PubMed ID: 32109757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.